Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Hengxiang, Wang"'
Autor:
Qian Wang, Yinggai Song, Dongmei Han, Hong Cai, Qiuhong Yan, Wei Liu, Hengxiang Wang, Xiaoli Zheng, Li Ding, Xiaoying Yuan
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 1 (2023)
ABSTRACTHormographiella aspergillata is a rare and emerging cause of invasive mould infections in patients with haematological malignancies, with a mortality rate of approximately 70%. Here, we present the first reported case of suspected disseminate
Externí odkaz:
https://doaj.org/article/924b38256f17427d87333a68d84e569d
Autor:
Yiming Liu, Li Ding, Bowen Zhang, Ziliang Deng, Yi Han, Sihan Wang, Shu Yang, Zeng Fan, Jing Zhang, Hongmin Yan, Dongmei Han, Lijuan He, Wen Yue, Hengxiang Wang, Yanhua Li, Xuetao Pei
Publikováno v:
Stem Cells Translational Medicine, Vol 9, Iss 6, Pp 661-673 (2020)
Abstract We reported a novel function of recombinant human thrombopoietin (TPO) in increasing hematopoietic stem and progenitor cell (HSPC) homing to the bone marrow (BM). Single doses of TPO treatment to the recipients immediately after BM transplan
Externí odkaz:
https://doaj.org/article/f0c862dd1eda42d2a495ccf929c32f95
Autor:
Xiao-Li Zheng, Hengxiang Wang, Ning Mao, Dong-Mei Han, Heng Zhu, Hong-Min Yan, Zi-Kuan Guo, Mei Xue, Ling Zhu, Jing Liu, Hong-Mei Ning, Li Ding
Publikováno v:
Cytotherapy. 24:205-212
Background aims Despite the great advances in immunosuppressive therapy for severe aplastic anemia (SAA), most patients are not completely cured. Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) has been recommended as an alternati
Autor:
Yan Yang, Hengxiang Wang, Jing Shao, Jiajun Xie, Cheng-Tao Zhang, Xiaoli Zheng, Beibei Gao, Hongchen Liu, Jinsong Yan
Publikováno v:
Frontiers of Medicine. 15:718-727
Severe aplastic anemia II (SAA-II) progresses from non-severe aplastic anemia (NSAA). The unavailability of efficacious treatment has prompted the need for haploidentical bone marrow transplantation (haplo-BMT) in patients lacking a human leukocyte a
Autor:
Xiaojuan Wei, Chaozhong Liu, Hengxiang Wang, Lisheng Wang, Fengjun Xiao, Zikuan Guo, Hongchao Zhang
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0147360 (2016)
Previous data have proven that microvesicles derived from hypoxia-induced mesenchymal stem cells (MSC-MVs) can be internalized into endothelial cells, enhancing their proliferation and vessel structure formation and promoting in vivo angiogenesis. Ho
Externí odkaz:
https://doaj.org/article/63533e83b3714a3b954fa052617c2fd7
Autor:
Dongmei, Han *, Jing, Liu *, Mei, Xue, Ling, Zhu, Hongmin, Yan, Zhidong, Wang, Li, Ding, Zikuan, Guo, Hengxiang, Wang **
Publikováno v:
In Cytotherapy September 2011 13(8):913-917
Autor:
Yuefeng Yang, Xiaoyun Liu, Fengjun Xiao, Shuya Xue, Qinqin Xu, Yue Yin, Huiyan Sun, Jie Xu, Hengxiang Wang, Qunwei Zhang, Hua Wang, Lisheng Wang
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0117573 (2015)
Differentiation induction is currently considered as an alternative strategy for treating chronic myelogenous leukemia (CML). Our previous work has demonstrated that Sprouty-related EVH1 domainprotein2 (Spred2) was involved in imatinib mediated cytot
Externí odkaz:
https://doaj.org/article/84a0cdf7951b4ac9b24eb3b41654831a
Publikováno v:
International Communications in Heat and Mass Transfer. 138:106398
Autor:
Xiaoli Zheng, Hongmin Yan, Dongmei Han, Li Ding, Ling Zhu, Jing Liu, Mei Xue, Sheng Li, Hengxiang Wang
Publikováno v:
Annals of hematology. 101(8)
Donor-specific anti-human leukocyte antigen (HLA) antibody (DSA) is associated with a higher incidence of graft failure and mortality in HLA-mismatched allograft settings. However, the optimal protocol of desensitization for patients with positive DS
Autor:
Feng-Jun Xiao, Hengxiang Wang, Yi-Kun Zhang, Xiaoyan Zhang, Hua Wang, Li Zhao, Dong-Mei Han, Zi-Kuan Guo, Li-Sheng Wang, Xiao-Pei Cao
Publikováno v:
Cytotherapy. 18:402-412
Background aims Specific and effective therapy for prevention or reversal of bronchiolitis obliterans (BO) is lacking. In this study, we evaluated the therapeutic effect of hepatocyte growth factor (HGF) gene modified mesenchymal stromal cells (MSCs)